Featured Publication Advancing Shared Goals Click here to read the full reportResearch Papers Savings from the introduction of BPaL and BPaLM regimens at the country level Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the PhilippinesFor the PressPress Contact:Jess Wiggsp | +1 646 616 8613e | jessica.wiggs@tballiance.org View the 2023 Annual Report